University and the Antidiabetic Food Centre (AFC) in Lund, Sweden. In 2015, the company’s second-generation soluble fiber AXOS was selected as a top new ingredient by the Nutrition Capital Network (NCN) in Europe and the US. In 2017, Carbiotix began development of its low-cost gut health testing platform and in 2018 launched the platform along with commencing a 600-person gut health study. In 2019, the company began to leverage data from its low-cost gut health testing platform to ramp up therapeutic development activities in line with its long-term strategy to create microbiome modulators based on its proprietary soluble fiber, isolated strains and novel delivery mechanisms.